Table 5: Clinicopathological features of osetosarcoma tissue samples for prognosis study.

Sample nameAgeGenderHistological subtypeSiteHuvos gradingPreoperation chemotheapy agentsMstastasis
(months)
Followup
(months)
Status

Metastasis within 2 years

OS0743MaleOsteoblasticPelvis2MTX, ADR/CDDP627DOD
OS1119MaleOsteoblasticDistal tibia3HD-MTX, ADR/CDDP1888NED
OS1667FemaleOsteoblasticDistal femur1938DOD
OS1713FemaleOsteoblasticProximal tibia1HD-MTX1551DOD
OS2261MaleOsteoblasticSpine57DOD
OS2619MaleOsteoblasticDistal femur1HD-MTX, CDDP1945AWD
OS2715FemaleOsteoblasticDistal femur3HD-MTX, IFO, ADR/CDDPAt diagnosis26DOD
OS289FemaleOsteoblasticProximal tibia4HD-MTX, CDDP/ADR, 651NED
OS4118MaleOsteoblasticPelvis1IFO, CDDP/ADRAt diagnosis18DOD
OS4418MaleOsteoblasticDistal femur1IFO/VPAt diagnosis3DOD
OS4618MaleChondroblasticDistal femur2IFO, CDDP/ADRAt diagnosis17NED
OS4714MaleChondroblasticProximal femur1IFO, CDDP/ADRAt diagnosis15AWD

No metastasis over 3 years

OS1814MaleOsteoblasticProximal tibia1HD-MTX, ADR/CDDP 73NED
OS2012MaleOsteoblasticDistal femur1HD-MTX, ADR/CDDP, IFO68NED
OS2414FemaleOsteoblasticDistal femur4HD-MTX, CDDP/ADR, 60NED
OS3219MaleOsteoblasticDistal femur1HD-MTX, CDDP/ADR, 47NED
OS3519FemaleFibroblasticProximal tibia3HD-MTX, CDDP/ADR40NED